+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Postpartum Depression Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4802072
  • Report
  • May 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Anikem Laboratories
  • Cipla Limited
  • Mylan N.V.
  • Sage Therapeutics
  • MORE
The report on the global postpartum depression treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global postpartum depression treatment market to grow with a healthy CAGR over the forecast period from 2019-2025. The study on postpartum depression treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on postpartum depression treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global postpartum depression treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global postpartum depression treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
  • Rising incidences of mood disorder associated with pregnancy across the globe
  • The increasing demand for antidepressant medication and talk therapies
2) Restraints
  • Unacceptance of Postpartum Depression
Research Methodology

A) Primary Research
The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with the author
2. Internal and External subject matter experts
3. Professionals and participants from the industry
The primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global postpartum depression treatment market is segmented on the basis of treatment type, and distribution channel.

The Global Postpartum Depression Treatment Market by Treatment Type
  • Anti - Depressant Drugs
o Bupropion
o Escitalopram
o Paroxetine
o Sertraline
o Desipramine
o Trimipramine
o Tranylcypromine
o Other Anti - Depressant Drugs
  • Psychotherapy
o Interpersonal Psychotherapy (IPT)
o Psychodynamic PsychotherapyCognitive Behavioral Therapy (CBT)
o Solution-Focused Brief Psychotherapy
o Other Psychotherapies

The Global Postpartum Depression Treatment Market by Distribution Channel
  • Drug Stores
  • E-commerce
  • Retail Pharmacies
  • Hospital Pharmacies
Company Profiles

The companies covered in the report include
  • Sumika Polymer Compounds (EU) Ltd
  • Mylan N.V.
  • Anikem Laboratories
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited
  • Sage Therapeutics
  • Intas Pharmaceuticals Ltd.
  • Shionogi & Company, Limited
  • Other Companies
What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the postpartum depression treatment market.
2. Complete coverage of all the segments in the postpartum depression treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global postpartum depression treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Anikem Laboratories
  • Cipla Limited
  • Mylan N.V.
  • Sage Therapeutics
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Postpartum Depression Treatment Market Highlights
2.2. Postpartum Depression Treatment Market Projection
2.3. Postpartum Depression Treatment Market Regional Highlights

3. Global Postpartum Depression Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Treatment Type
3.4.2. Growth Matrix Analysis by Distribution Channel
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Postpartum Depression Treatment Market

4. Postpartum Depression Treatment Market Macro Indicator Analysis

5. Global Postpartum Depression Treatment Market by Treatment Type
5.1. Antidepressant Drugs
5.1.1. Bupropion
5.1.2. Escitalopram
5.1.3. Paroxetine
5.1.4. Sertraline
5.1.5. Desipramine
5.1.6. Trimipramine
5.1.7. Tranylcypromine
5.1.8. Other Antidepressant Drugs
5.2. Psychotherapy
5.2.1. Interpersonal Psychotherapy (IPT)
5.2.2. Psychodynamic Psychotherapy
5.2.3. Cognitive Behavioral Therapy (CBT)
5.2.4. Solution-Focused Brief Psychotherapy
5.2.5. Other Psychotherapies

6. Global Postpartum Depression Treatment Market by Distribution Channel
6.1. Drug Stores
6.2. E-commerce
6.3. Retail Pharmacies
6.4. Hospital Pharmacies

7. Global Postpartum Depression Treatment Market by Region 2019-2025
7.1. North America
7.1.1. North America Postpartum Depression Treatment Market by Treatment Type
7.1.2. North America Postpartum Depression Treatment Market by Distribution Channel
7.1.3. North America Postpartum Depression Treatment Market by Country
7.2. Europe
7.2.1. Europe Postpartum Depression Treatment Market by Treatment Type
7.2.2. Europe Postpartum Depression Treatment Market by Distribution Channel
7.2.3. Europe Postpartum Depression Treatment Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Postpartum Depression Treatment Market by Treatment Type
7.3.2. Asia-Pacific Postpartum Depression Treatment Market by Distribution Channel
7.3.3. Asia-Pacific Postpartum Depression Treatment Market by Country
7.4. RoW
7.4.1. RoW Postpartum Depression Treatment Market by Treatment Type
7.4.2. RoW Postpartum Depression Treatment Market by Distribution Channel
7.4.3. RoW Postpartum Depression Treatment Market by Sub-region

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Postpartum Depression Treatment Market
8.2. Companies Profiles
8.2.1. Sumika Polymer Compounds (EU) Ltd
8.2.2. Mylan N.V.
8.2.3. Anikem Laboratories
8.2.4. Sun Pharmaceutical Industries Limited
8.2.5. Cipla Limited
8.2.6. Sage Therapeutics
8.2.7. Intas Pharmaceuticals Ltd.
8.2.8. Shionogi & Company, Limited
8.2.9. Other Companies

9. Appendix
9.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Sumika Polymer Compounds (EU) Ltd
  • Mylan N.V.
  • Anikem Laboratories
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited
  • Sage Therapeutics
  • Intas Pharmaceuticals Ltd.
  • Shionogi & Company, Limited
Note: Product cover images may vary from those shown
Adroll
adroll